Delcath Systems (DCTH) Competitors $11.94 -0.28 (-2.29%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DCTH vs. RXST, INMD, MDXG, ESTA, BLFS, PLSE, AORT, EMBC, CBLL, and LQDAShould you be buying Delcath Systems stock or one of its competitors? The main competitors of Delcath Systems include RxSight (RXST), InMode (INMD), MiMedx Group (MDXG), Establishment Labs (ESTA), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), Artivion (AORT), Embecta (EMBC), CeriBell (CBLL), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry. Delcath Systems vs. RxSight InMode MiMedx Group Establishment Labs BioLife Solutions Pulse Biosciences Artivion Embecta CeriBell Liquidia RxSight (NASDAQ:RXST) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings, media sentiment and community ranking. Do analysts rate RXST or DCTH? RxSight presently has a consensus price target of $62.13, suggesting a potential upside of 63.31%. Delcath Systems has a consensus price target of $21.50, suggesting a potential upside of 80.07%. Given Delcath Systems' stronger consensus rating and higher probable upside, analysts clearly believe Delcath Systems is more favorable than RxSight.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RxSight 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in RXST or DCTH? 78.8% of RxSight shares are held by institutional investors. Comparatively, 61.1% of Delcath Systems shares are held by institutional investors. 9.4% of RxSight shares are held by insiders. Comparatively, 17.9% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, RXST or DCTH? RxSight has a beta of 1.11, suggesting that its share price is 11% more volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Does the MarketBeat Community favor RXST or DCTH? RxSight received 16 more outperform votes than Delcath Systems when rated by MarketBeat users. Likewise, 70.77% of users gave RxSight an outperform vote while only 25.64% of users gave Delcath Systems an outperform vote. CompanyUnderperformOutperformRxSightOutperform Votes4670.77% Underperform Votes1929.23% Delcath SystemsOutperform Votes3025.64% Underperform Votes8774.36% Does the media prefer RXST or DCTH? In the previous week, RxSight had 10 more articles in the media than Delcath Systems. MarketBeat recorded 11 mentions for RxSight and 1 mentions for Delcath Systems. RxSight's average media sentiment score of 0.75 beat Delcath Systems' score of 0.44 indicating that RxSight is being referred to more favorably in the media. Company Overall Sentiment RxSight Positive Delcath Systems Neutral Is RXST or DCTH more profitable? RxSight has a net margin of -23.92% compared to Delcath Systems' net margin of -150.70%. RxSight's return on equity of -14.00% beat Delcath Systems' return on equity.Company Net Margins Return on Equity Return on Assets RxSight-23.92% -14.00% -12.51% Delcath Systems -150.70%-338.16%-104.02% Which has preferable valuation & earnings, RXST or DCTH? Delcath Systems has lower revenue, but higher earnings than RxSight. RxSight is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRxSight$89.08M17.21-$48.61M-$0.83-45.83Delcath Systems$22.64M16.86-$47.68M-$1.35-8.84 SummaryRxSight beats Delcath Systems on 13 of the 18 factors compared between the two stocks. Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Get Delcath Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for DCTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCTH vs. The Competition Export to ExcelMetricDelcath SystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$390.72M$4.41B$5.18B$9.31BDividend YieldN/A44.87%4.78%4.06%P/E Ratio-8.8425.33127.8817.55Price / Sales16.8646.521,262.65139.48Price / CashN/A44.2041.1037.95Price / Book16.587.254.894.92Net Income-$47.68M$13.83M$119.61M$225.78M7 Day Performance2.40%-2.81%14.55%-1.47%1 Month Performance27.16%3.10%17.43%5.36%1 Year Performance274.29%45.60%35.33%22.71% Delcath Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCTHDelcath Systems2.5017 of 5 stars$11.94-2.3%$21.50+80.1%+283.1%$390.72M$22.64M-8.8476Gap DownRXSTRxSight3.355 of 5 stars$39.11+4.9%$62.13+58.8%-3.1%$1.58B$89.08M-46.59220INMDInMode3.6931 of 5 stars$18.08-1.0%$22.60+25.0%-21.3%$1.52B$423.75M9.87480Short Interest ↓News CoveragePositive NewsMDXGMiMedx Group3.2141 of 5 stars$9.46+3.3%$12.00+26.8%+5.7%$1.39B$342.80M16.65895ESTAEstablishment Labs2.8057 of 5 stars$46.32+0.7%$60.60+30.8%+79.2%$1.30B$153.07M-17.83960Positive NewsBLFSBioLife Solutions0.7394 of 5 stars$27.20+1.9%$28.29+4.0%+83.1%$1.26B$146.96M-25.19409Short Interest ↑PLSEPulse Biosciences1.9808 of 5 stars$20.50+16.1%N/A+94.8%$1.26B$700,000.000.00140News CoveragePositive NewsAORTArtivion2.1391 of 5 stars$29.02+0.3%$31.80+9.6%+56.0%$1.22B$384.90M-1,446.501,500EMBCEmbecta4.1041 of 5 stars$19.84+1.7%$23.00+15.9%+15.2%$1.15B$1.12B14.712,200Short Interest ↓CBLLCeriBellN/A$29.04-0.6%$32.60+12.3%N/A$1.04B$60.04M0.00N/ALQDALiquidia2.4958 of 5 stars$11.07+1.4%$24.00+116.8%+48.1%$936.93M$15.61M-6.7050Positive News Related Companies and Tools Related Companies RxSight Competitors InMode Competitors MiMedx Group Competitors Establishment Labs Competitors BioLife Solutions Competitors Pulse Biosciences Competitors Artivion Competitors Embecta Competitors CeriBell Competitors Liquidia Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DCTH) was last updated on 12/17/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Delcath Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Delcath Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DCTH Stock Alerts